Shenzhen, Guangdong, China The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. When the investment is from Co-Stone Capital the average startup value is 500 millions - 1 billion dollars. The high activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Among the most successful fund investment fields, there are Artificial Intelligence, Digital Media. Among the most popular portfolio startups of the fund, we may highlight SenseTime, Chuchujie, Carzone. The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Co-Stone Capital, startups are often financed by Hejun Capital, Tencent Holdings, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Green Pine Capital Partners, Fortune Capital, CICC. In the next rounds fund is usually obtained by Vinno Capital, ZSVC, Tiger Global Management.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Haodian Technology | $23M | 23 Feb 2023 | - | ||
Adaps Photonics | $15M | 10 Feb 2023 | Futian District, Guangdong Province, China | ||
Hochuen Medical Technology | 07 Feb 2023 | Shenzhen, Guangdong, China | |||
Anshi New Energy | $46M | 19 Jan 2023 | Shenzhen, Guangdong, China | ||
Boyin Bio | $15M | 12 Jan 2023 | Shenzhen, Guangdong, China | ||
Core Medical Technology | 30 Dec 2022 | Shenzhen, Guangdong, China | |||
InnerMedical | $46M | 19 Dec 2022 | Futian District, Guangdong Province, China | ||
Readline | $46M | 09 Dec 2022 | Futian District, Guangdong Province, China | ||
Galaxis Automotion | 08 Dec 2022 | Shanghai, China |
– IASO Biotherapeutics announced the completion of $108m Series C to advance the global development of novel cell therapies and biologics for oncology and autoimmune diseases.
– The round was led by CDH Baifu, and followed by CCB International, with strong participation from Everbright Limited, Co-Stone Capital, CNCB Capital and Plaisance Capital.
– Current shareholder GL Ventures also participated.
– Since its founding in 2017, IASO Bio has raised more than $178m.
– Proceeds from the financing will be used to accelerate the global development and regulatory submissions of multiple novel cell therapies.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Haodian Technology | $23M | 23 Feb 2023 | - | ||
Adaps Photonics | $15M | 10 Feb 2023 | Futian District, Guangdong Province, China | ||
Hochuen Medical Technology | 07 Feb 2023 | Shenzhen, Guangdong, China | |||
Anshi New Energy | $46M | 19 Jan 2023 | Shenzhen, Guangdong, China | ||
Boyin Bio | $15M | 12 Jan 2023 | Shenzhen, Guangdong, China | ||
Core Medical Technology | 30 Dec 2022 | Shenzhen, Guangdong, China | |||
InnerMedical | $46M | 19 Dec 2022 | Futian District, Guangdong Province, China | ||
Readline | $46M | 09 Dec 2022 | Futian District, Guangdong Province, China | ||
Galaxis Automotion | 08 Dec 2022 | Shanghai, China |
Get matched with relevant funds
